Davis's Drug Guide for Nurses

(9)
Davis's Drug Guide for Nurses image
ISBN-10:

0803609396

ISBN-13:

9780803609396

Edition: 8th
Released: Jul 15, 2002
Publisher: F A Davis Co
Format: Paperback, 1257 pages

Description:

This text is a comprehensive, contemporary and easy-to-use drug reference. The book features 4600 trade and generic drugs; and 50 monographs new to the edition, along with all the latest FDA information on new medications/warnings, dosage forms and unlabelled uses, life-span considerations and product withdrawals. IV information includes: dose; dilution; syringe/Y-site/additive/solution compatibility and incompatibility; rate; clinical precautions; direct IV; intermittent infusion; continuous infusion; life-span considerations; and IV compatibility and incompatibility. 475 commonly used combination drugs are completely updated and side effects organized by body systems with the most frequent problems underlined and life-threatening problems capitalized and set in a second colour for easy identification.

Best prices to buy, sell, or rent ISBN 9780803609396




Related Books

Frequently Asked Questions about Davis's Drug Guide for Nurses

You can buy the Davis's Drug Guide for Nurses book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $8.99 on Amazon and is available from 8 sellers at the moment.

If you’re interested in selling back the Davis's Drug Guide for Nurses book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Davis's Drug Guide for Nurses book, the best buyback offer comes from and is $ for the book in good condition.

The Davis's Drug Guide for Nurses book is in very low demand now as the rank for the book is 5,006,948 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.